Assessment of Irisin and Nesfatin-1 Levels in Non-Obese and Obese Women with Polycystic Ovarian Syndrome

Background: In the developed world, some of the most common ovarian disorders include polycystic ovarian syndrome (PCOS), ovulatory dysfunction, hyperandrogenism, and polycystic ovaries which are the most characteristic in this woman endocrinopathy. It is associated with hyperinsulinemia and metabol...

Full description

Saved in:
Bibliographic Details
Main Authors: Ali Al-Sajaad Mohammed Al-Azzawi, Hiba Resheed Behayaa, Ban Aamer Mousa
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-04-01
Series:Medical Journal of Babylon
Subjects:
Online Access:https://doi.org/10.4103/MJBL.MJBL_320_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849703649000816640
author Ali Al-Sajaad Mohammed Al-Azzawi
Hiba Resheed Behayaa
Ban Aamer Mousa
author_facet Ali Al-Sajaad Mohammed Al-Azzawi
Hiba Resheed Behayaa
Ban Aamer Mousa
author_sort Ali Al-Sajaad Mohammed Al-Azzawi
collection DOAJ
description Background: In the developed world, some of the most common ovarian disorders include polycystic ovarian syndrome (PCOS), ovulatory dysfunction, hyperandrogenism, and polycystic ovaries which are the most characteristic in this woman endocrinopathy. It is associated with hyperinsulinemia and metabolic disorder. Objective: To estimate irisin, nesfatin-,1 and other biochemical parameters in obese and non-obese women with PCOS. Materials and Methods: The study comprised 90 women aged between 18 and 40 years, divided into two sub-groups. The first group consisted of 45 obese women with PCOS, and the second group consisted of 45 non-obese women with PCOS. Smokers, women with hypertension, or women consuming oral contraceptives were excluded from the groups. To determine whether the women were obese or not, body mass index was used. Results: The results of the study revealed that obese women with PCOS showed significantly higher levels of BMI, irisin, nesfatin-1, insulin, fasting glucose, and HOMA-IR compared to non-obese women (P ≤ 0.05). However, no significant differences were found in LH, FSH, LH/FSH ratio, and total testosterone between the groups (P < 0.05). Conclusion: Irisin and nesfatin-1 levels surged in women with PCOS make them critical biomarkers in the progress of PCOS in obese and non-obese women.
format Article
id doaj-art-680e005edf1745d6bc160f71bc5a2a1b
institution DOAJ
issn 1812-156X
2312-6760
language English
publishDate 2025-04-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Medical Journal of Babylon
spelling doaj-art-680e005edf1745d6bc160f71bc5a2a1b2025-08-20T03:17:09ZengWolters Kluwer Medknow PublicationsMedical Journal of Babylon1812-156X2312-67602025-04-0122255656010.4103/MJBL.MJBL_320_24Assessment of Irisin and Nesfatin-1 Levels in Non-Obese and Obese Women with Polycystic Ovarian SyndromeAli Al-Sajaad Mohammed Al-AzzawiHiba Resheed BehayaaBan Aamer MousaBackground: In the developed world, some of the most common ovarian disorders include polycystic ovarian syndrome (PCOS), ovulatory dysfunction, hyperandrogenism, and polycystic ovaries which are the most characteristic in this woman endocrinopathy. It is associated with hyperinsulinemia and metabolic disorder. Objective: To estimate irisin, nesfatin-,1 and other biochemical parameters in obese and non-obese women with PCOS. Materials and Methods: The study comprised 90 women aged between 18 and 40 years, divided into two sub-groups. The first group consisted of 45 obese women with PCOS, and the second group consisted of 45 non-obese women with PCOS. Smokers, women with hypertension, or women consuming oral contraceptives were excluded from the groups. To determine whether the women were obese or not, body mass index was used. Results: The results of the study revealed that obese women with PCOS showed significantly higher levels of BMI, irisin, nesfatin-1, insulin, fasting glucose, and HOMA-IR compared to non-obese women (P ≤ 0.05). However, no significant differences were found in LH, FSH, LH/FSH ratio, and total testosterone between the groups (P < 0.05). Conclusion: Irisin and nesfatin-1 levels surged in women with PCOS make them critical biomarkers in the progress of PCOS in obese and non-obese women.https://doi.org/10.4103/MJBL.MJBL_320_24enzyme-linked immunosorbent assayiririsinnesfatin-1pcos
spellingShingle Ali Al-Sajaad Mohammed Al-Azzawi
Hiba Resheed Behayaa
Ban Aamer Mousa
Assessment of Irisin and Nesfatin-1 Levels in Non-Obese and Obese Women with Polycystic Ovarian Syndrome
Medical Journal of Babylon
enzyme-linked immunosorbent assay
ir
irisin
nesfatin-1
pcos
title Assessment of Irisin and Nesfatin-1 Levels in Non-Obese and Obese Women with Polycystic Ovarian Syndrome
title_full Assessment of Irisin and Nesfatin-1 Levels in Non-Obese and Obese Women with Polycystic Ovarian Syndrome
title_fullStr Assessment of Irisin and Nesfatin-1 Levels in Non-Obese and Obese Women with Polycystic Ovarian Syndrome
title_full_unstemmed Assessment of Irisin and Nesfatin-1 Levels in Non-Obese and Obese Women with Polycystic Ovarian Syndrome
title_short Assessment of Irisin and Nesfatin-1 Levels in Non-Obese and Obese Women with Polycystic Ovarian Syndrome
title_sort assessment of irisin and nesfatin 1 levels in non obese and obese women with polycystic ovarian syndrome
topic enzyme-linked immunosorbent assay
ir
irisin
nesfatin-1
pcos
url https://doi.org/10.4103/MJBL.MJBL_320_24
work_keys_str_mv AT alialsajaadmohammedalazzawi assessmentofirisinandnesfatin1levelsinnonobeseandobesewomenwithpolycysticovariansyndrome
AT hibaresheedbehayaa assessmentofirisinandnesfatin1levelsinnonobeseandobesewomenwithpolycysticovariansyndrome
AT banaamermousa assessmentofirisinandnesfatin1levelsinnonobeseandobesewomenwithpolycysticovariansyndrome